Clinical trials researching treatments and preventative measures for Covid-19 are underway at McFarland Clinic.
The Covid-19 clinical trials are being conducted by PMG Research of McFarland Clinic. PMG Research Inc is a global integrated network of clinical research facilities, conducting clinical trials since 1979. Their research facility is is staffed by an experienced team in a variety of specialties including allergy, cardiology, dermatology, neurology, obstetrics and gynecology, and oncology.
“We partner with value-based healthcare institutions and multi-specialty practices that also see the value of clinical research and the benefit of offering it as a care option to the patients for whom they serve,” PMG Research manager of clinical operations Erin Hackett said.
McFarland Clinic adult medicine physician Jennifer Killion, MD, is a principal investigator in these Covid-19 clinical trials. In her role, Killion is responsible for making sure that protocols are followed, monitoring of patient safety and signing off on all of the delegation. Killion was involved in a 2019 pneumonia vaccine trial before the Covid trials began.
McFarland Clinic neurologist and director of research David Moore, MD, helps to oversee clinical trials from the clinical perspective. PMG finds studies the clinic and providers are interested in doing, and puts together teams to begin facilitating the studies. When Covid began spreading in Iowa Moore said that no one expected the shift in these studies to happen so quickly, especially with an infectious disease that was quickly changing.
“There are been viruses that have been out there that are coronaviruses. At the time we were made aware of Covid-19, no one ever thought it would be like this, like a rapidly affecting virus because it is spread by air and not by touch,” Moore said.
Persons who want more information can visit mcfarlandclinic.com/trials. Persons who are interested in enrolling in clinical trials with McFarland Clinic and PMG Research can call 515-956-4159.
